logo
Search orAI Icon𝛼SK
ENTITY

Lexaria Bioscience (LEXX US)

10
Analysis
Health Care • Canada
Lexaria Bioscience Corp improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier ingestion methods. The Company's technology can be applied to ingestible product formats such as foods, beverages, oral suspensions, tablets, and capsules. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio.
more
bullish•Lexaria Bioscience
•03 Oct 2025 03:00•Issuer-paid

LEXX: Biodistribution Study Results

Lexaria is a biotechnology company seeking to enhance the bioavailability of multiple drug agents using DehydraTECH (DHT), its technology using...

Logo
Share
bullish•Lexaria Bioscience
•31 Jul 2025 23:00•Issuer-paid

LEXX: Third Quarter Results

Lexaria is a biotechnology company seeking to enhance the bioavailability of multiple drug agents using DehydraTECH (DHT), its technology using...

Logo
Share
bullish•Lexaria Bioscience
•16 Jun 2025 23:00•Issuer-paid

LEXX: GLP-1-H25-5 Study Complete

Zacks Small-Cap Research Note for Lexaria Bioscience Corp. (LEXX)

Logo
Share
bullish•Lexaria Bioscience
•28 Apr 2025 22:00•Issuer-paid

LEXX: Second Quarter Results

Lexaria is a biotechnology company seeking to enhance the bioavailability of multiple drug agents using DehydraTECH (DHT), its technology using...

Logo
Share
bullish•Lexaria Bioscience
•24 Apr 2025 22:00•Issuer-paid

LEXX: Second Quarter Results

Lexaria is a biotechnology company seeking to enhance the bioavailability of multiple drug agents using DehydraTECH (DHT), its technology using...

Logo
Share

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x